Changes of serum cardiotropin I and cystatin C in preeclampsia and significance thereof

Xiaofu Yang,Donghong Lu,Zhengping Wang,Jing He,Hanzhi Wang,Minyue Dong

2006-01-01

Abstract:Objective: To investigate the changes and of serum cardiotropin I (cTN I) and cystatin C in preeclampsia clinical significance thereof. Methods: Peripheral blood samples were collected from 40 women with preeclampsia, aged 29 (18-39), with the medium gestational age of 35 weeks, and 40 age- and gestational age-matched controls. Serum cTN I and cystatin C were determined with ELISA and serum levels of creatinin kinase, creatinine, and uric acid were assayed by automatic biochemical analyzer. Comparison was made between the 2 groups. Results: The serum cTn I of the preclampsia group was 0.59 μg/L ± 0.42 μg/L, significantly higher than that of the control group (0.09 μg/L ± 0.22 μg/L P < 0.001), and the serum cystatin C of the preclampsia group was 1.64 mg/L ± 0.47 mg/L, significantly higher than that of the control group (1.08 mg/L ± 0.19 mg/L, P < 0.001). And the serum cardiotropin I and cystatin C concentrations of the patients with severe preeclampsia were 0.66 μg /L ± 0.40 μg/L and 1.72 mg/L ± 0.46 mg/L respectively, both significantly higher than those of the patients with mild preclampsia (0.17 μg/L ± 0.26 μg/L and 1.21 mg/L ± 0.37 mg/L respectively, P < 0.001 and 0.05 respectively). Conclusion: Serum cTn I and cystatin C levels are elevated in preeclampsia and the elevation is associated with the severity of preeclampsia, suggesting that serum concentrations of cTn I and cystatin C are useful markers in the early diagnosis of cardiac and renal injury in patients of preeclampsia.